Phoenix Wealth Advisors Iovance Biotherapeutics, Inc. Transaction History

Phoenix Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $3,243 - $5,415	-196 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$16.33 - $33.07 $240,883 - $487,815	-14,751 Reduced 98.69%	196 $5,000
Q1 2021 Apr 12, 2021	BUY	$28.67 - $52.59 $83,544 - $153,247	2,914 Added 24.22%	14,947 $482,000
Q4 2020 Feb 05, 2021	BUY	$28.04 - $50.26 $337,405 - $604,778	12,033 New	12,033 $558,000

306

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.23B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.